Font: Financial Modeling Prep • Aug 14, 2026
Genasys (NASDAQ: GNSS) is a company that provides critical communications systems and solutions for public safety and defense. On August 14, 2026, an analyst from Roth Capital adjusted their price target for Genasys to $3.60. At the time, the stock was trading at $1.73, which suggests a potential increase of about 108% to meet the new target, offering a compelling investment opportunity.
This analyst rating follows the company's recent financial report for its fiscal third quarter of 2026. Genasys announced revenue of $7.3 million, which is a decrease from the $9.9 million reported in the same quarter of the previous year. The company attributes this decline in revenue to temporary issues rather than a fundamental drop in customer demand for its specialized communications technology.
Specifically, the revenue shortfall was caused by supply-chain constraints affecting a defense program and a temporary work suspension in Puerto Rico. As highlighted by Business Wire, these events caused some revenue to be recognized in a later quarter. Despite these challenges, the company's gross margin, a key profitability metric, improved significantly to 57.1% from 26.3% a year ago, showcasing operational efficiency.
Chief Executive Officer Richard Danforth stated that the factors delaying revenue are now being resolved. The company's operating loss, which is the loss before interest and taxes, also improved, narrowing to $4.0 million from $5.9 million in the prior year. Management maintains its forecast for fiscal 2026 to be a record year for both revenue and profitability, signaling a positive market outlook.
Supporting this optimistic outlook, the supply-chain issue has been fixed and production has restarted, as detailed in a Genasys Q3 Earnings Call Highlights report. Work in Puerto Rico has also resumed. The company's backlog of orders remains strong and its pipeline for new business continues to grow, according to management commentary published by Seeking Alpha, reinforcing its position in the critical communications market.
|
MDXH§>
MDxHealth S.A.
|
$0.81
74.89%
|
|
SURG§>
SurgePays, Inc.
|
$0.28
14.36%
|
|
VBIO§>
Valion Bio, Inc.
|
$0.19
11.59%
|
|
NU§>
Nu Holdings Ltd.
|
$15.23
9.33%
|
|
TSLL§>
Direxion Daily TSLA Bull 2X ETF
|
$8.76
1.39%
|
|
OTLK§>
Outlook Therapeutics, Inc.
|
$0.76
-14.90%
|
|
ONDS§>
Ondas Holdings Inc.
|
$9.24
3.70%
|
|
SPCX§>
Space Exploration Technologies Corp.
|
$140.00
-0.91%
|
|
INTC§>
Intel Corp.
|
$102.50
-1.97%
|
|
ONFO§>
Onfolio Holdings, Inc.
|
$2.59
12.12%
|